A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE

被引：129
作者：
Kudo, Masatoshi [1 ]
机构：
[1] Kindai Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohnohigashi, Osaka 5898511, Japan
来源：
LIVER CANCER | 2019年 / 8卷 / 05期
关键词：
CLINICAL-PRACTICE GUIDELINES; TRANSARTERIAL CHEMOEMBOLIZATION; GROWTH-FACTOR; SORAFENIB; CANCER; SUBCLASSIFICATION; CRITERIA; PROPOSAL; REFRACTORINESS; HETEROGENEITY;
D O I：
10.1159/000502905
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：299 / 311
页数：13
相关论文
共 46 条
[1]   Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma [J].
Abou-Alfa, G. K. ;
Meyer, T. ;
Cheng, A. -L. ;
El-Khoueiry, A. B. ;
Rimassa, L. ;
Ryoo, B. -Y. ;
Cicin, I. ;
Merle, P. ;
Chen, Y. H. ;
Park, J. -W. ;
Blanc, J. -F. ;
Bolondi, L. ;
Klumpen, H. -J. ;
Chan, S. L. ;
Zagonel, V. ;
Pressiani, T. ;
Ryu, M. -H. ;
Venook, A. P. ;
Hessel, C. ;
Borgman-Hagey, A. E. ;
Schwab, G. ;
Kelley, R. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (01) :54-63
[2]  
[Anonymous], 2018, J FORMOS MED ASSOC, DOI [DOI 10.1016/J.JFMA.2017.09.007, 10.1016/j.jfma.2017.09.007]
[3]   Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2 [J].
Arizumi, Tadaaki ;
Minami, Tomohiro ;
Chishina, Hirokazu ;
Kono, Masashi ;
Takita, Masahiro ;
Yada, Norihisa ;
Hagiwara, Satoru ;
Minami, Yasunori ;
Ida, Hiroshi ;
Ueshima, Kazuomi ;
Kamata, Ken ;
Minaga, Kosuke ;
Komeda, Yoriaki ;
Takenaka, Mamoru ;
Sakurai, Toshiharu ;
Watanabe, Tomohiro ;
Nishida, Naoshi ;
Kudo, Masatoshi .
DIGESTIVE DISEASES, 2017, 35 (06) :589-597
[4]   Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma [J].
Arizumi, Tadaaki ;
Ueshima, Kazuomi ;
Minami, Tomohiro ;
Kono, Masashi ;
Chishina, Hirokazu ;
Takita, Masahiro ;
Kitai, Satoshi ;
Inoue, Tatsuo ;
Yada, Norihisa ;
Hagiwara, Satoru ;
Minami, Yasunori ;
Sakurai, Toshiharu ;
Nishida, Naoshi ;
Kudo, Masatoshi .
LIVER CANCER, 2015, 4 (04) :253-262
[5]   Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions [J].
Bolondi, Luigi ;
Burroughs, Andrew ;
Dufour, Jean-Francois ;
Galle, Peter R. ;
Mazzaferro, Vincenzo ;
Piscaglia, Fabio ;
Raoul, Jean Luc ;
Sangro, Bruno .
SEMINARS IN LIVER DISEASE, 2012, 32 (04) :348-359
[6]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[7]   Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma [J].
Bruix, Jordi ;
Reig, Maria ;
Sherman, Morris .
GASTROENTEROLOGY, 2016, 150 (04) :835-853
[8]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[9]   Re-evaluating transarterial chemoembolization for the treatment of Hepatocellular Carcinoma: Consensus recommendations and review by an International Expert Panel [J].
Cheng, Ann Lii ;
Amarapurkar, Deepak ;
Chao, Yee ;
Chen, Pei-Jer ;
Geschwind, Jean-Francois ;
Goh, Khean L. ;
Han, Kwang-Hyub ;
Kudo, Masatoshi ;
Lee, Han Chu ;
Lee, Rheun-Chuan ;
Lesmana, Laurentius A. ;
Lim, Ho Yeong ;
Paik, Seung Woon ;
Poon, Ronnie T. ;
Tan, Chee-Kiat ;
Tanwandee, Tawesak ;
Teng, Gaojun ;
Park, Joong-Won .
LIVER INTERNATIONAL, 2014, 34 (02) :174-183
[10]   Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].
Cheng, Ann-Lii ;
Kang, Yoon-Koo ;
Chen, Zhendong ;
Tsao, Chao-Jung ;
Qin, Shukui ;
Kim, Jun Suk ;
Luo, Rongcheng ;
Feng, Jifeng ;
Ye, Shenglong ;
Yang, Tsai-Sheng ;
Xu, Jianming ;
Sun, Yan ;
Liang, Houjie ;
Liu, Jiwei ;
Wang, Jiejun ;
Tak, Won Young ;
Pan, Hongming ;
Burock, Karin ;
Zou, Jessie ;
Voliotis, Dimitris ;
Guan, Zhongzhen .
LANCET ONCOLOGY, 2009, 10 (01) :25-34
12345